US visa bond scheme creates new consideration for medical travel insurers

The US decision to make its visa-bond programme permanent could create additional challenges for travel insurers and assistance providers supporting customers travelling for treatment or emergency care.

Under rules effective from 3 August, applicants from 50 countries, including 30 in Africa, who are otherwise eligible for B-1 business or B-2 tourist visas may be required to post a bond of up to US$20,000. The permanent scheme replaces a 2025 pilot, which offered bonds of $5,000, $10,000 or $15,000. Reuters reports that the new programme removes the $5,000 tier while increasing the ceiling to $20,000.

The State Department confirms B-2 visas can be used for medical treatment, meaning the bond could represent an additional upfront financial requirement for patients travelling to the US, alongside treatment, travel, and insurance costs.

For insurers and assistance providers, the bigger concern may be the knock-on effects of visa issues once a medical journey is underway. Treatment may already be scheduled, travel booked, and care arrangements in place when an immigration problem forces changes.

Providers could then face the operational consequences of disrupted treatment, altered transport arrangements, and potentially costly logistics, alongside the underlying medical event.

The development highlights the need to identify immigration requirements earlier when planning medical travel, particularly where customers have significant upfront commitments.

For brokers and assistance teams, visa eligibility is becoming another variable to consider when assessing whether a medical trip can proceed as planned – and how an insured journey could be affected if it cannot.